Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
58.7 USD | +1.57% | +2.38% | -6.66% |
May. 23 | Deutsche Bank Initiates Incyte to Hold Rating With $55 Price Target | MT |
May. 21 | Incyte Acquires 2 Office Buildings in Delaware | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-6.64% | 12.99B | B- | ||
-1.85% | 89.87B | A- | ||
-1.05% | 37.57B | A- | ||
-11.83% | 32.75B | B- | ||
+61.85% | 26.47B | A | ||
-21.14% | 14.25B | C | ||
-11.42% | 11.93B | D+ | ||
-47.67% | 10.84B | B | ||
+5.99% | 9.11B | B+ | ||
-19.53% | 7.32B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- INCY Stock
- Ratings Incyte Corporation